Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2023 to Q4 2025

Type / Class
Equity / Common stock, par value $ 0.000001 per share
Symbol
TIL on Nasdaq
Shares outstanding
6,505,400
Price per share
$7.11
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
2,543,805
Total reported value
$27,981,700
% of total 13F portfolios
0%
Share change
-158,367
Value change
-$4,191,273
Number of holders
28
Price from insider filings
$7.11
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Vivo Capital IX, LLC 4.5% $7,169,276 292,743 Vivo Capital IX, LLC 30 Jun 2025

As of 31 Dec 2025, 28 institutional investors reported holding 2,543,805 shares of Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL). This represents 39% of the company’s total 6,505,400 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL) together control 39% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BML Capital Management, LLC 9.9% 645,600 0% 6.3% $7,101,600
CPMG Inc 6.3% 410,922 0% 18% $4,520,142
Vivo Capital, LLC 4.5% 292,743 0% 0.21% $3,220,173
MILLENNIUM MANAGEMENT LLC 3.7% 242,772 +23% 0% $2,670,492
Siren, L.L.C. 3.1% 203,933 0% 0.07% $2,243,263
VANGUARD GROUP INC 2.9% 191,060 +14% 0% $2,101,660
MORGAN STANLEY 1.4% 88,979 -14% 0% $978,769
RENAISSANCE TECHNOLOGIES LLC 1% 67,800 0% $745,800
DIMENSIONAL FUND ADVISORS LP 0.94% 61,025 -24% 0% $670,989
BlackRock, Inc. 0.79% 51,213 -17% 0% $563,343
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 0.77% 50,000 0% 0% $550,000
CITADEL ADVISORS LLC 0.73% 47,335 0% $520,685
GEODE CAPITAL MANAGEMENT, LLC 0.66% 42,706 +0.87% 0% $469,950
AlphaQuest LLC 0.57% 37,279 +153% 0.02% $410,069
LPL Financial LLC 0.51% 33,080 -1.8% 0% $363,875
Quadrature Capital Ltd 0.3% 19,198 0% $211,178
STATE STREET CORP 0.27% 17,595 0% 0% $193,545
Americana Partners, LLC 0.25% 16,176 +52% 0% $177,936
XTX Topco Ltd 0.19% 12,267 0% $134,937
BARCLAYS PLC 0.16% 10,145 +65% 0% $111,595
ROYAL BANK OF CANADA 0.02% 1,368 +378% 0% $15,000
UBS Group AG 0.01% 359 -94% 0% $3,949
RHUMBLINE ADVISERS 0% 114 0% 0% $1,254
Farther Finance Advisors, LLC 0% 70 -37% 0% $770
EQ WEALTH ADVISORS, LLC 0% 40 0% $440

Institutional Holders of Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 2,543,805 $27,981,700 -$4,191,273 $11.00 28
2025 Q3 2,655,269 $47,423,593 -$2,963,439 $17.86 33
2025 Q2 2,751,266 $57,311,087 -$11,020,093 $20.83 37
2025 Q1 3,353,462 $58,216,200 -$97,479 $17.36 42
2024 Q4 3,339,375 $63,749,218 -$66,077,020 $19.09 39
2024 Q3 3,419,403 $230,187,844 +$81,138,546 $67.32 48
2024 Q2 2,328,646 $23,960,769 -$220,805 $10.29 29
2024 Q1 2,348,572 $25,363,318 +$3,416,073 $10.80 30
2023 Q4 2,037,306 $15,523,621 +$13,556,922 $7.62 27